The HLA locus contains novel foetal susceptibility alleles for congenital heart block with significant paternal influence
Authors:
- A. MälarstigAMA. Mälarstig
- L. AlfredssonLAL. Alfredsson
- L. KlareskogLKL. Klareskog
- The Swedish Congenital Heart Block Study GroupTGThe Swedish Congenital Heart Block Study Group
- 20 January 2014
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 275 (6) , 640-651
Abstract
Objective: The main aim of this study was to identify foetal susceptibility genes on chromosome six for Ro/SSA autoantibody‐mediated congenital heart block.Subjects and Design: Single nucleotide polymorphism (SNP) genotyping of individuals in the Swedish Congenital Heart Block (CHB) study population was performed. Low‐resolution HLA‐A, ‐Cw and ‐DRB1 allele typing was carried out in 86 families comprising 339 individuals (86 Ro/SSA autoantibody‐positive mothers, 71 fathers, 87 CHB index cases and 95 unaffected siblings).Results: A case–control comparison between index cases and population‐based out‐of‐study controls (n = 1710) revealed association of CHB with 15 SNPs in the 6p21.3 MHC locus at a chromosome‐wide significance of P < 2.59 × 10−6 (OR 2.21–3.12). In a family‐based analysis of association of SNP markers as well as distinct MHC class I and II alleles with CHB, HLA‐DRB1*04 and HLA‐Cw*05 variants were significantly more frequently transmitted to affected individuals (P < 0.03 and P < 0.05, respectively), whilst HLA‐DRB1*13 and HLA‐Cw*06 variants were significantly less often transmitted to affected children (P < 0.04 and P < 0.03). We further observed marked association of increased paternal (but not maternal) HLA‐DRB1*04 transmission to affected offspring (P < 0.02).Conclusions: HLA‐DRB1*04 and HLA‐Cw*05 were identified as novel foetal HLA allele variants that confer susceptibility to CHB in response to Ro/SSA autoantibody exposure, whilst DRB1*13 and Cw*06 emerged as protective alleles. Additionally, we demonstrated a paternal contribution to foetal susceptibility to CHB for the first time.Keywords
Funding Information
- Swedish Research Council
- Torsten and Ragnar Söderberg Foundation
- Göran Gustafsson Foundation
- King Gustaf the V the 80-year foundation
- Goljes memory Foundation
- Lars Hiertas Memory Foundation
- Swedish Foundation for Strategic Research
- Stockholm County Council
- Heart-Lung Foundation
- Karolinska Institute and the Swedish Rheumatism Association
This publication has 59 references indexed in Scilit:
- Congenital heart block: evidence for a pathogenic role of maternal autoantibodiesArthritis Research & Therapy, 2012
- A Novel Role of Endothelin-1 in Linking Toll-like Receptor 7-mediated Inflammation to Fibrosis in Congenital Heart BlockJournal of Biological Chemistry, 2011
- Identification of candidate loci at 6p21 and 21q22 in a genome‐wide association study of cardiac manifestations of neonatal lupusArthritis & Rheumatism, 2010
- Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseasesProceedings of the National Academy of Sciences, 2009
- Antibodies to amino acid 200–239 (p200) of Ro52 as serological markers for the risk of developing congenital heart blockClinical and Experimental Immunology, 2008
- Likelihood-Based Association Analysis for Nuclear Families and Unrelated Subjects with Missing Genotype DataHuman Heredity, 2008
- TRAF1–C5as a Risk Locus for Rheumatoid Arthritis — A Genomewide StudyNew England Journal of Medicine, 2007
- Gene map of the extended human MHCNature Reviews Genetics, 2004
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritisArthritis & Rheumatism, 1987